SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027007
Filing Date
2021-05-12
Accepted
2021-05-12 16:16:00
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20210331.htm   iXBRL 10-Q 1461804
2 EX-31.1 rna-ex311_8.htm EX-31.1 10337
3 EX-31.2 rna-ex312_7.htm EX-31.2 10145
4 EX-32.1 rna-ex321_9.htm EX-32.1 6780
5 EX-32.2 rna-ex322_6.htm EX-32.2 6753
  Complete submission text file 0001564590-21-027007.txt   6309895

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rna-20210331.xsd EX-101.SCH 52697
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20210331_cal.xml EX-101.CAL 43156
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20210331_def.xml EX-101.DEF 175118
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210331_lab.xml EX-101.LAB 422783
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210331_pre.xml EX-101.PRE 318229
11 EXTRACTED XBRL INSTANCE DOCUMENT rna-10q_20210331_htm.xml XML 1068859
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 21915292
SIC: 2834 Pharmaceutical Preparations